NanoAct™ is a unique colored particle developed using Asahi Kasei's core cellulose technology.
Compared to traditional colloidal gold or latex particles, NanoAct™ offers higher color intensity per particle, enabling high sensitivity, rapid diagnostics, multiple detection, and cost-effective assay development.
Because the particles are dyed, a wide variety of colors is available, allowing clear line differentiation for each analyte.
By utilizing NanoAct™, researchers can design multiplex lateral flow immunoassays that combine high sensitivity, speed, multi-analyte detection, and cost efficiency—providing versatile solutions for next-generation lateral flow immunoassays.
Model studies
The results of hCG and Troponin I (TnI) assays are provided as reference examples.
Results of a
clinical test
of influenza test kits
The performance of commercially available kits using
NanoAct ™ is presented.
2021/9/26-9/30 2021 AACC ANNUAL SCIENTIFIC MEETING & CLINICAL LAB EXPO
CareStart™ COVID-19 Antigen test kit using NanoAct™ launched in the U.S.